Combination of Gemcitabine with Cell-Penetrating Peptides: A Pharmacokinetic Approach Using in Silico Tools
Open Access
- 4 November 2019
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 9 (11) , 693
Abstract
Gemcitabine is an anticancer drug used to treat a wide range of solid tumors and is a first line treatment for pancreatic cancer. Our group has previously developed novel conjugates of gemcitabine with cell-penetrating peptides (CPP), and here we report some preliminary data regarding the pharmacokinetics of gemcitabine, two gemcitabine-CPP conjugates and respective CPP gathered from GastroPlus™, and analyze these results considering our previous evaluation of gemcitabine release and conjugates’ bioactivity. Additionally, seeking to shed some light on the relation between the penetration ability of CPP and their physicochemical properties, chemical descriptors for the 20 natural amino acids were calculated, a new principal property scale (z-scale) was created and CPP prediction models were developed, establishing quantitative structure-activity relationships (QSAR). The z-scores of the peptides conjugated with gemcitabine are presented and analyzed with the aforementioned data.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (POCI-01-0145-FEDER-007274, UID/QUI/50006/2019, IF/00092/2014/CP1255/CT0004, PD/BD/135120/2017)
- European Regional Development Fund (COMPETE 2020 and Portugal 2020)
This publication has 38 references indexed in Scilit:
- Antimicrobial Peptides Design by Evolutionary Multiobjective OptimizationPLOS Computational Biology, 2013
- Helical poly(arginine) mimics with superior cell-penetrating and molecular transporting propertiesChemical Science, 2013
- In silico approaches for designing highly effective cell penetrating peptidesJournal of Translational Medicine, 2013
- Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer TherapiesPharmaceuticals, 2012
- Prediction of Cell Penetrating Peptides by Support Vector MachinesPLOS Computational Biology, 2011
- Integrating pharmacogenetics into gemcitabine dosing—time for a change?Nature Reviews Clinical Oncology, 2011
- Clinical pharmacology and pharmacogenetics of gemcitabineDrug Metabolism Reviews, 2009
- Predicting cell-penetrating peptidesAdvanced Drug Delivery Reviews, 2008
- Analysis and prediction of antibacterial peptidesBMC Bioinformatics, 2007
- Pattern recognition by means of disjoint principal components modelsPattern Recognition, 1976